Fas Ligand/TNFSF6 Antibody MAB126-100 from R&D Systems, a Bio-Techne Brand

Product Specs
ItemFas Ligand/TNFSF6 Antibody
CompanyR&D Systems, a Bio-Techne Brand
Price Pricing Info Supplier Page View Company Product Page
Catalog NumberMAB126-100
Quantity100 ug (also 500 ug, 25 ug)
ApplicationsFlow Cytometry, Neutralization, ELISA Capture (Matched Antibody Pair)
Conjugate/TagUnconjugated
FormatLyophilized from a 0.2 µm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS
ReactivityHuman
TargetFas Ligand/TNFSF6
IsotypeIgG2b
Clone100419
HostMouse
ImmunogenChinese hamster ovary cell line CHO-derived recombinant human Fas Ligand/TNFSF6, Pro134-Leu281, Accession # P48023
NCBI Full Gene NameFas ligand
NCBI Gene AliasesCD178, CD95L, CD95-L, APTL, APT1LG1, ALPS1B, FASL, TNLG1A, TNFSF6
ClonalityMonoclonal
ConcentrationLYOPH
PurityProtein A or G purified from hybridoma culture supernatant
Brand/TrademarkR&D Systems, a Bio-Techne Brand
Antibody TypePrimary Antibodies
StorageUse a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution

Available conjugates: Unconjugated

Specificity: Detects human Fas Ligand/TNFSF6 in ELISAs

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

(4) Immunological Properties of Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial CellsStem cell reportsSeptember 11, 2018Idelson M, Alper R, Obolensky A, Yachimovich-Cohen N, Rachmilewitz J, Ejzenberg A, Beider E, Banin E, Reubinoff B.

(7) Interleukin-10-producing LAG3⁺ regulatory T cells are associated with disease activity and abatacept treatment in rheumatoid arthritisArthritis research & therapyMay 16, 2017Nakachi S, Sumitomo S, Tsuchida Y, Tsuchiya H, Kono M, Kato R, Sakurai K, Hanata N, Nagafuchi Y, Tateishi S, et al.

(8) Combination of IAP antagonist and IFNγ activates novel caspase-10- and RIPK1-dependent cell death pathwaysCell death and differentiationMarch 1, 2017Tanzer MC, Khan N, Rickard JA, Etemadi N, Lalaoui N, Spall SK, Hildebrand JM, Segal D, Miasari M, Chau D, et al.

(10) The Therapeutic Effect of Pamidronate on Lethal Avian Influenza A H7N9 Virus Infected Humanized MicePloS oneJanuary 1, 2015Zheng J, Wu WL, Liu Y, Xiang Z, Liu M, Chan KH, Lau SY, Lam KT, To KK, Chan JF, et al.

(11) Reciprocal complementation of the tumoricidal effects of radiation and natural killer cellsPloS oneJanuary 1, 2013Yang KL, Wang YS, Chang CC, Huang SC, Huang YC, Chi MS, Chi KH.

(12) Potent anti-tumor killing activity of the multifunctional Treg cell line HOZOT against human tumors with diverse originsInternational journal of oncologyMay 1, 2011Inoue T, Tashiro Y, Takeuchi M, Otani T, Tsuji-Takayama K, Okochi A, Mukae Y, Koreishi M, Yamasaki F, Kumon H, et al.

(15) A novel mechanism of CD40-induced apoptosis of carcinoma cells involving TRAF3 and JNK/AP-1 activationCell death and differentiationOctober 1, 2006Georgopoulos NT, Steele LP, Thomson MJ, Selby PJ, Southgate J, Trejdosiewicz LK.

Fas Ligand/TNFSF6 Antibody